Search research articles
Contact Us
Filters
Showing results (141-150 of 1,137) with videos related to
Page
of 114
Sort By:
Current Opinion in Lipidology
|
November 6, 2004
Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology
Kausik K Ray, Christopher P Cannon
The American Journal of Cardiology
|
November 14, 2006
Critical pathways using platelet testing to potentially optimize the use of oral antiplatelet therapy
Christopher P Cannon, Dalton S McLean
The American Journal of Cardiology
|
December 16, 2006
Clinical trials update from the annual scientific session of the American College of Cardiology 2006
Christopher P Cannon, Deepak L Bhatt
Journal of the American College of Cardiology
|
May 16, 2006
Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors
Eli V Gelfand, Christopher P Cannon
Expert Opinion on Investigational Drugs
|
March 1, 2006
Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors
Eli V Gelfand, Christopher P Cannon
Nature
|
June 12, 2009
Immunology: Immunity's ancient arms
Gary W Litman, John P Cannon
Cardiovascular Research
|
January 1, 1990
Raised vascular calcium in an animal model: effects on aortic function
E P Cannon, B J Williams
Nature Clinical Practice. Cardiovascular Medicine
|
July 29, 2006
Update on lipid-lowering therapy and LDL-cholesterol targets
Stephen D Wiviott, Christopher P Cannon
Critical Pathways in Cardiology
|
March 15, 2008
Brigham and Women's Hospital admission order set for unstable angina/non-ST elevation myocardial infarction
David A Morrow, Christopher P Cannon
The Journal of Emergency Medicine
|
July 1, 1995
Waiting for Godot: use of chemical markers in the emergency department evaluation of chest pain
C P Cannon, R M Walls
Page
of 114
Search research articles
Search
Showing results (141-150 of 1,137) with videos related to
Sort By:
Page
of 114
Current Opinion in Lipidology
|
November 6, 2004
Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology
Kausik K Ray, Christopher P Cannon
The American Journal of Cardiology
|
November 14, 2006
Critical pathways using platelet testing to potentially optimize the use of oral antiplatelet therapy
Christopher P Cannon, Dalton S McLean
The American Journal of Cardiology
|
December 16, 2006
Clinical trials update from the annual scientific session of the American College of Cardiology 2006
Christopher P Cannon, Deepak L Bhatt
Journal of the American College of Cardiology
|
May 16, 2006
Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors
Eli V Gelfand, Christopher P Cannon
Expert Opinion on Investigational Drugs
|
March 1, 2006
Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors
Eli V Gelfand, Christopher P Cannon
Nature
|
June 12, 2009
Immunology: Immunity's ancient arms
Gary W Litman, John P Cannon
Cardiovascular Research
|
January 1, 1990
Raised vascular calcium in an animal model: effects on aortic function
E P Cannon, B J Williams
Nature Clinical Practice. Cardiovascular Medicine
|
July 29, 2006
Update on lipid-lowering therapy and LDL-cholesterol targets
Stephen D Wiviott, Christopher P Cannon
Critical Pathways in Cardiology
|
March 15, 2008
Brigham and Women's Hospital admission order set for unstable angina/non-ST elevation myocardial infarction
David A Morrow, Christopher P Cannon
The Journal of Emergency Medicine
|
July 1, 1995
Waiting for Godot: use of chemical markers in the emergency department evaluation of chest pain
C P Cannon, R M Walls
Page
of 114